| Emerging coronaviruses: Genome structure, replication, and pathogenesis | 2020/02/07 | English | 1,877 |
| Outbreak of pneumonia of unknown etiology in Wuhan, China: The mystery and the miracle | 2020/02/12 | English | 1,803 |
| The neuroinvasive potential of SARS‐CoV2 may play a role in the respiratory failure of COVID‐19 patients | 2020/03/11 | English | 1,324 |
| Coronavirus infections and immune responses | 2020/02/07 | English | 1,144 |
| Development and clinical application of a rapid IgM‐IgG combined antibody test for SARS‐CoV‐2 infection diagnosis | 2020/04/13 | English | 956 |
| The cytokine storm and COVID‐19 | 2020/09/30 | English | 864 |
| Tocilizumab treatment in COVID‐19: A single center experience | 2020/04/15 | English | 862 |
| Norwalk virus: How infectious is it? | 2008/06/12 | English | 837 |
| Postdischarge symptoms and rehabilitation needs in survivors of COVID‐19 infection: A cross‐sectional evaluation | 2020/08/17 | English | 836 |
| Unique epidemiological and clinical features of the emerging 2019 novel coronavirus pneumonia (COVID‐19) implicate special control measures | 2020/03/29 | English | 831 |
| Updated understanding of the outbreak of 2019 novel coronavirus (2019‐nCoV) in Wuhan, China | 2020/02/12 | English | 810 |
| COVID‐19 patients' clinical characteristics, discharge rate, and fatality rate of meta‐analysis | 2020/03/23 | English | 802 |
| Evaluation of coronavirus in tears and conjunctival secretions of patients with SARS‐CoV‐2 infection | 2020/03/12 | English | 738 |
| Potential interventions for novel coronavirus in China: A systematic review | 2020/03/03 | English | 726 |
| Central nervous system involvement by severe acute respiratory syndrome coronavirus‐2 (SARS‐CoV‐2) | 2020/06/09 | English | 662 |
| Diagnostic utility of clinical laboratory data determinations for patients with the severe COVID‐19 | 2020/04/10 | English | 624 |
| Clinical features and treatment of COVID‐19 patients in northeast Chongqing | 2020/04/01 | English | 604 |
| Rapid and quantitative detection of human adenovirus DNA by real‐time PCR | 2003/04/09 | English | 594 |
| Understanding of COVID‐19 based on current evidence | 2020/03/05 | English | 570 |
| The presence of SARS‐CoV‐2 RNA in the feces of COVID‐19 patients | 2020/04/25 | English | 515 |
| An interferon‐γ‐related cytokine storm in SARS patients | 2004/12/15 | English | 514 |
| Cross‐species transmission of the newly identified coronavirus 2019‐nCoV | 2020/02/19 | English | 513 |
| Omicron variant of SARS‐CoV‐2: Genomics, transmissibility, and responses to current COVID‐19 vaccines | 2022/01/23 | English | 492 |
| Coronavirus disease 2019: What we know? | 2020/03/28 | English | 447 |
| The impact of COPD and smoking history on the severity of COVID‐19: A systemic review and meta‐analysis | 2020/05/17 | English | 434 |
| Population‐based study of antibody to the human polyomaviruses BKV and JCV and the simian polyomavirus SV40 | 2003/07/08 | English | 413 |
| Stability issues of RT‐PCR testing of SARS‐CoV‐2 for hospitalized patients clinically diagnosed with COVID‐19 | 2020/04/05 | English | 407 |
| Composition and divergence of coronavirus spike proteins and host ACE2 receptors predict potential intermediate hosts of SARS‐CoV‐2 | 2020/03/11 | English | 400 |
| Predictors of mortality in hospitalized COVID‐19 patients: A systematic review and meta‐analysis | 2020/07/11 | English | 387 |
| Clinical characteristics of 3062 COVID‐19 patients: A meta‐analysis | 2020/06/24 | English | 378 |